Abstract: Schwannomatosis is a rare tumor syndrome characterized by the presence of multiple benign non-vestibular, non-intradermal schwannomas and by the absence of neurofibromatosis type 1 or 2 syndromes. Multiple schwannomas are clinically and genetically distinct from neurofibromatosis, and the main treatment in case of symptomatic lesions is represented by surgical resection. In case of asymptomatic lesions, the indicated treatment is neuroimaging follow-up (MRI). We are presenting the case of a patient with three schwannomas of the cauda equina, as well as the treatment strategy in the case of this rare pathology.
Introduction
Schwannomatosis is a syndrome characterized by the existence of multiple schwannomas at the level of the spinal cord, cranial or peripheral nerves, but without the presence of vestibular schwannomas, ependymomas, meningiomas, or astrocytomas, which are encountered in neurofibromatosis type 2 (NF2) (15, 22, 25, 27, 28) . Nonetheless, infrequently, the existence of meningiomas or ependymomas has been reported within schwannomatosis (3, 9) .
Schwannomatosis was reported for the first time in 1973, as neurofibromatosis type 3 (18) , and even though some researchers considered it to be an incomplete form, or a subcategory of NF2 (7), the subsequent genetic and molecular studies have shown that schwannomatosis is a separate genetic and clinical syndrome (13, 20, 24) . Schwannomatosis represents 3-5% of the patients with schwannomas (11, 23, 24) .
Short case report
We are presenting the case of a 59 year old female patient who was hospitalized for the first time in 2011, at "Prof. Dr. N. Oblu" Clinical Emergency Hospital of Iaşi, for long standing low back pain and bilateral sciatica with insidious onset 10 months previously, as well as paraparesis with insidious onset 5 months previously. The imaging explorations carried out in 2011 revealed three lumbar spinal schwannomas located at the level of the cauda equina ( Figure 1) . Moreover, the head and spine MRI did not detect the existence of other schwannomas. Surgery was performed with the complete resection of the symptomatic schwannoma (the bigger schwannoma) (Figure 2 ). The subsequent anatomopathological examination was of schwannoma with Antoni A and B regions (Figure 3 ), and the postoperative evolution was favourable, without neurological deficits or residual radicular pain. Even though the patient did not have clinical symptoms, she was monitored every year through spine MRI neuroimaging, which did not identify significant increases in the volume of the tumors. In 2016, the patient was admitted again in our neurosurgery unit for the occurrence of an important long standing low back pain and left side sciatica about 6 months before. The lumbar spine MRI performed (2016) 
Discussion
Spinal schwannomas are benign tumors that develop from the schwann cells of the nerves and represent approximately one third of all benign primary spinal tumors (17) . The majority of schwannomas are solitary lesions that can affect one or several nerves (5, 10), but they can also be multiple, suggesting the presence of syndromes, the most frequent of which is NF2.
Spinal schwannomas unassociated with neurofibromatosis was reported for the first time in 1993 by the American Daras M., at the Metropolitan Hospital from New York (5).
The schwannomatosis diagnosis is supported by the anatomopathological diagnosis which, apart from the Antoni A and Antoni B regions (26) , also highlights other histological findings, such as: nerve oedema, intraneural growth pattern and myxoid stroma (21) . Like in NF2, the schwannomas are growing slowly and do not turn into malignant lesions (2).
The genetics of schwannomatosis is complex and not yet fully understood (14) , given that over 90% of the sporadic cases and 50% of the familial cases of schwannomatosis do not have an identified genetic mutation (19, 20) . An associated germline mutation inactivating the SMARCB1 gene is encountered in only 40-50% of the familial forms, and in less than 10% in the sporadic cases (20) . Moreover, the family history is present only in 15-25% of the cases (20) .
The first clinical sign of patients who are suffering from schwannomatosis is pain on the tract of the implied nerve (8, 12, 16) , unlike patients suffering from NF2, who seek medical care for the occurrence of neurological deficit, which is represented in 95% of the cases by hearing impairment (6). In our patient's case, the onset symptomatology was represented by long standing low back pain and bilateral sciatica, followed by the insidious onset of neurological deficit.
The age of onset of schwannomatosis is represented by the fourth decade (1, 11, 24) , unlike patients with NF2, who seek medical care at an earlier age (5) .
Even though some criteria for diagnosing schwannomatosis have been proposed, they are currently unclear. In 1997, Jacoby et al. proposed as a criterion for schwannomatosis the presence of 2 or more schwannomas, in the absence of vestibular schwannomas, in patients over the age of 18 (13 (4) and follow-up in non-symptomatic cases. Moreover, in our patient's case, the biggest schwannoma which was actually symptomatic, was initially resected (Figure 1,  Figure 2 ). For the other two smaller, nonsymptomatic schwannomas ( Figure 5 ), a conservative follow-up treatment was decided upon. Five years after the initial surgery, the patient was hospitalized for the occurrence of pain, due to the increased size of the second schwannoma. Thus, surgery with the complete resection of the two tumors was performed, having a favourable postoperative evolution.
Conclusions
In the case of multiple spinal schwannomas, head neuroimaging (MRI) and audiological testing must also be taken into consideration in order to exclude NF2. In spite of the similarities between NF2 and schwannomatosis, they are two distinctive entities, both genetically and clinically, which can pose diagnosis problems. The MacCollin criteria can be useful to differentiate between these two syndromes. In the case of patients with spinal schwannomatosis, we recommend surgical treatment in the case of symptomatic tumors, and conservative follow-up treatment in case nonsymptomatic tumors. 
